Clinical Trials
64 trials5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Application and Comparison of [68Ga]Ga-FAPI-04 PET, [18F]FDG PET, and Contrast-Enhanced MRI in Predicting Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
PD-L1 Specific [68Ga]Ga-THP-PDL1-3 Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Comparison of Whole Body DWI to FDG PET
University of California, San Francisco
Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma
Peking University Cancer Hospital & Institute
CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
City of Hope Medical Center
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
Thomas Jefferson University
Diffusion MRI for Head and Neck Cancer
NYU Langone Health
FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma
Jonsson Comprehensive Cancer Center
RefleXion PET/CT Imaging Performance in Patients With Various Malignancies
City of Hope Medical Center
Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer
Thomas Jefferson University
The Exploration of 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients
Affiliated Hospital of Jiangnan University
Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular Imaging
Peking University Cancer Hospital & Institute
Research on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Target Visualization
Peking University Cancer Hospital & Institute
18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic Radiosurgery
M.D. Anderson Cancer Center
PET Scan in Treating Patients With Metastatic Prostate Cancer
Memorial Sloan Kettering Cancer Center
Dynamic PET/CT
University Hospital, Geneva
Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell Cancer
M.D. Anderson Cancer Center
FDG PET-MRI for the Diagnosis of Spinal Cord Lesions
M.D. Anderson Cancer Center
Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors
University of Utah
PET/MRI in Endometrial Cancer
Massachusetts General Hospital
Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study
University Health Network, Toronto
Digital PET Scan for the Prediction of Outcomes in Patients With Locally Advanced Oropharyngeal Cancer
Ohio State University Comprehensive Cancer Center
Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer
University of Washington
PET-HCC01
Assistance Publique - Hôpitaux de Paris
MIM
Centre Georges Francois Leclerc
68Ga-FAPI-04 PET Imaging in Early Response Evaluation of Rectal Cancer Patients Treated With Immunotherapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Multimodalitic Imaging in the N-stage of Lung Cancer
Peking University First Hospital
PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor
Peking University Cancer Hospital & Institute
Clinical Application of 18F-PEG3-FPN PET Imaging in Diagnosis and Staging of Malignant Melanoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma
Masonic Cancer Center, University of Minnesota
68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients
Peking Union Medical College Hospital
A Head-to-head Comparative Study of 18F-PSMA-1007 PET/CT and 18F-FDG PET/CT Imaging in Multiple Myeloma
First Hospital of China Medical University
F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy
University of Washington
Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer
Abramson Cancer Center at Penn Medicine
Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)
Abramson Cancer Center at Penn Medicine
PET-MRI in Diagnosing Patients With Colon or Rectal Cancer
Case Comprehensive Cancer Center
ACRIN6685
American College of Radiology Imaging Network
PET/MRI and PET/CT in Diagnosing Younger Patients With Cancer
Case Comprehensive Cancer Center
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
University of Washington
ACRIN6678
American College of Radiology Imaging Network
TRANSTEP
Centre Georges Francois Leclerc
Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer
Ohio State University Comprehensive Cancer Center
Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
Boston Medical Center
Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery
Roswell Park Cancer Institute
PET/CT Evaluation of Treatment Response in Breast Cancer
Vanderbilt-Ingram Cancer Center
Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
Stanford University
Positron Emission Tomography in Determining Stage of Esophageal Cancer
Alliance for Clinical Trials in Oncology